Invivyd, Inc.
corporate_fare Company Profile
Invivyd, Inc. (NASDAQ:IVVD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for IVVD at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Pivotal COVID Drug Trial Fully Enrolls, IDMC Gives Positive Safety Nod; Invivyd Reports Doubled Revenue
- Invivyd Reports Strong Q4 Revenue, $226.7M Cash, Advances VYD2311 to Phase 3 with Fast Track Designation
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$53.43M
Net Income
-$52.49M
Diluted EPS
-$0.30
Op. Cash Flow
-$58.13M
Free Cash Flow
-$58.29M
Operating Income
-$55.56M
Cash & Equivalents
$226.69M
Debt / Equity
0.00×
Net Margin
-98.2%
Shares Outstanding
281.99M sh
Source: 10-K · filed 2026-03-05 · accession 0001193125-26-092547
show_chartPrice Chart
Loading chart...